BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Paraneoplastic Cerebellar Degeneration

Below is an extended Paraneoplastic Cerebellar Degeneration research listing. Click here to return to the Paraneoplastic Cerebellar Degeneration main in depth entry.

Recent Publications on Paraneoplastic Cerebellar Degeneration:

Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: An autopsy case study.
Several antineuronal antibodies are associated with paraneoplastic...
Direct Link
15th August, 2008
Neurology Department, Hospital Arnau de Vilanova, Lleida, Spain.
Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
The association of high levels of autoantibodies to glutamic acid...
Direct Link
9th August, 2008
Service of Neurology and Laboratory of Hormonal, Hospital Clinic and
Sporadic fatal insomnia masquerading as a paraneoplastic cerebellar syndrome.
BACKGROUND: Sporadic fatal insomnia is a rare prion disease that has...
Direct Link
5th August, 2008
Neuroimmunology Unit, Department of Neurology, University of Rochester
[Renal cell carcinoma presenting as paraneoplastic neurological dysfunction] 29th July, 2008
Servicio de Neurologia, Complejo Hospitalario de Jaen.
[A case of paraneoplastic cerebellar degeneration associated with small cell lung cancer showing marked response to intravenous immunoglobulin] 25th July, 2008
Division of Pulmonary Medicine, Department of Medicine, Jichi Medical
ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer.
Patients with isolated ZIC4 antibodies usually have paraneoplastic...
Direct Link
22nd July, 2008
Service of Neurology Hospital Clinic, Universitat de Barcelona and
Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration.
Paraneoplastic cerebellar degeneration (PCD) is a rare immune mediated...
Direct Link
18th July, 2008
Department of Neurology, Clinical Center Nuernberg South, Breslauerstr.
Paraneoplastic syndromes of the CNS.
Major advances in the management of paraneoplastic neurologic disorders...
Direct Link
24th June, 2008
Division of Neuro-oncology, Department of Neurology, University of
A case of paraneoplastic cerebellar ataxia secondary to renal cell carcinoma.
A 64-year-old female patient presented with acute cerebellar ataxia. After...
Direct Link
12th June, 2008
Department of Internal Medicine, Heartland Regional Medical Center, St.
Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
Paraneoplastic cerebellar degeneration (PCD) is a rare paraneoplastic...
Direct Link
11th June, 2008
Department of Medicine, Beth Israel Medical Center, Albert Einstein
Small cell lung cancer. 25th April, 2008
Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton
Neuro-ophthalmologic manifestations of paraneoplastic syndromes.
Paraneoplastic syndromes with neuro-ophthalmologic manifestations may...
Direct Link
24th April, 2008
Department of Neurology, University of Pennsylvania School of Medicine,
Paraneoplastic cerebellar degeneration as a presentation of breast cancer - a case report and review of the literature.
ABSTRACT: Paraneoplastic cerebellar degeneration is part of a rare...
Direct Link
23rd April, 2008
Breast Surgery Unit, St George's Hospital NHS Trust, London, UK.
A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers.
A patient with paraneoplastic cerebellar degeneration due to anti-Purkinje...
Direct Link
23rd April, 2008
Department of Neurology, University Hospital, Linkoping, Sweden.
Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates.
The role of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography...
Direct Link
26th February, 2008
Division of Nuclear Medicine, Hospital of University of Pennsylvania, 3400
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional